Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A

NCT00496015 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

750

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Streptococcal

Interventions

BIOLOGICAL: Pneumococcal conjugate vaccine GSK1024850A.
BIOLOGICAL: Infanrix hexa.
BIOLOGICAL: Meningococcal vaccine GSK134612.
DRUG: Paracetamol.

Sponsor

GlaxoSmithKline